American Samoa
Hepatitis B
Download HBV dataPrevalence of chronic HBV (HBsAg+)
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 5.38 (4.45 - 6.28) | 2019 | Modelled | IHME |
| 5.45 (4.51 - 6.44) | 2018 | Modelled | IHME |
| 5.5 (4.46 - 6.67) | 2017 | Modelled | IHME |
| 5.57 (4.56 - 6.56) | 2016 | Modelled | IHME |
| 5.61 (4.55 - 6.64) | 2015 | Modelled | IHME |
| 5.61 (4.60 - 6.62) | 2014 | Modelled | IHME |
| 5.6 (4.58 - 6.60) | 2013 | Modelled | IHME |
| 5.59 (4.56 - 6.57) | 2012 | Modelled | IHME |
| 5.58 (4.56 - 6.54) | 2011 | Modelled | IHME |
| 5.57 (4.48 - 6.57) | 2010 | Modelled | IHME |
| 5.59 (4.49 - 6.60) | 2009 | Modelled | IHME |
| 5.62 (4.49 - 6.65) | 2008 | Modelled | IHME |
| 5.65 (4.48 - 6.76) | 2007 | Modelled | IHME |
| 5.68 (4.50 - 6.82) | 2006 | Modelled | IHME |
| 5.69 (4.48 - 6.86) | 2005 | Modelled | IHME |
| 5.67 (4.51 - 6.80) | 2004 | Modelled | IHME |
| 5.62 (4.53 - 6.69) | 2003 | Modelled | IHME |
| 5.55 (4.54 - 6.57) | 2002 | Modelled | IHME |
| 5.5 (4.51 - 6.50) | 2001 | Modelled | IHME |
| 5.48 (4.49 - 6.49) | 2000 | Modelled | IHME |
| 5.51 (4.53 - 6.53) | 1999 | Modelled | IHME |
| 5.58 (4.56 - 6.71) | 1998 | Modelled | IHME |
| 5.66 (4.59 - 6.91) | 1997 | Modelled | IHME |
| 5.73 (4.58 - 7.08) | 1996 | Modelled | IHME |
| 5.76 (4.57 - 7.18) | 1995 | Modelled | IHME |
| 5.76 (4.56 - 7.16) | 1994 | Modelled | IHME |
| 5.75 (4.57 - 7.12) | 1993 | Modelled | IHME |
| 5.73 (4.56 - 7.08) | 1992 | Modelled | IHME |
| 5.7 (4.56 - 6.98) | 1991 | Modelled | IHME |
| 5.65 (4.53 - 6.86) | 1990 | Modelled | IHME |
Showing out of
Show more
Children under-5 years
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 2.57 (1.80 - 3.36) | 2019 | Modelled | IHME |
| 2.55 (1.75 - 3.31) | 2018 | Modelled | IHME |
| 2.55 (1.72 - 3.40) | 2017 | Modelled | IHME |
| 2.59 (1.77 - 3.48) | 2016 | Modelled | IHME |
| 2.63 (1.81 - 3.67) | 2015 | Modelled | IHME |
| 2.62 (1.81 - 3.62) | 2014 | Modelled | IHME |
| 2.59 (1.79 - 3.53) | 2013 | Modelled | IHME |
| 2.56 (1.75 - 3.48) | 2012 | Modelled | IHME |
| 2.53 (1.73 - 3.45) | 2011 | Modelled | IHME |
| 2.52 (1.71 - 3.47) | 2010 | Modelled | IHME |
| 2.54 (1.74 - 3.48) | 2009 | Modelled | IHME |
| 2.58 (1.79 - 3.50) | 2008 | Modelled | IHME |
| 2.64 (1.83 - 3.56) | 2007 | Modelled | IHME |
| 2.69 (1.88 - 3.61) | 2006 | Modelled | IHME |
| 2.71 (1.88 - 3.65) | 2005 | Modelled | IHME |
| 2.71 (1.87 - 3.63) | 2004 | Modelled | IHME |
| 2.7 (1.86 - 3.60) | 2003 | Modelled | IHME |
| 2.69 (1.84 - 3.59) | 2002 | Modelled | IHME |
| 2.68 (1.82 - 3.61) | 2001 | Modelled | IHME |
| 2.68 (1.81 - 3.65) | 2000 | Modelled | IHME |
| 2.69 (1.82 - 3.64) | 1999 | Modelled | IHME |
| 2.72 (1.82 - 3.63) | 1998 | Modelled | IHME |
| 2.75 (1.80 - 3.68) | 1997 | Modelled | IHME |
| 2.78 (1.79 - 3.75) | 1996 | Modelled | IHME |
| 2.79 (1.76 - 3.81) | 1995 | Modelled | IHME |
| 2.8 (1.80 - 3.79) | 1994 | Modelled | IHME |
| 2.8 (1.81 - 3.82) | 1993 | Modelled | IHME |
| 2.8 (1.83 - 3.86) | 1992 | Modelled | IHME |
| 2.8 (1.86 - 3.89) | 1991 | Modelled | IHME |
| 2.8 (1.88 - 3.91) | 1990 | Modelled | IHME |
Showing out of
Show more
HBV-related death rate
National
Download| Value (per 100,000) | Year | Type | Source |
|---|---|---|---|
| 8.49 (6.81 - 10.70) | 2019 | Modelled | IHME |
| 8.37 (6.70 - 10.50) | 2018 | Modelled | IHME |
| 8.25 (6.57 - 10.20) | 2017 | Modelled | IHME |
| 8.12 (6.60 - 10) | 2016 | Modelled | IHME |
| 7.95 (6.47 - 9.69) | 2015 | Modelled | IHME |
| 7.87 (6.48 - 9.55) | 2014 | Modelled | IHME |
| 7.75 (6.45 - 9.28) | 2013 | Modelled | IHME |
| 7.58 (6.30 - 9.05) | 2012 | Modelled | IHME |
| 7.42 (6.26 - 8.80) | 2011 | Modelled | IHME |
| 7.18 (6.05 - 8.50) | 2010 | Modelled | IHME |
| 7 (5.87 - 8.28) | 2009 | Modelled | IHME |
| 6.82 (5.76 - 8.09) | 2008 | Modelled | IHME |
| 6.62 (5.57 - 7.88) | 2007 | Modelled | IHME |
| 6.51 (5.47 - 7.72) | 2006 | Modelled | IHME |
| 6.3 (5.28 - 7.52) | 2005 | Modelled | IHME |
| 6.22 (5.18 - 7.50) | 2004 | Modelled | IHME |
| 6.18 (5.17 - 7.40) | 2003 | Modelled | IHME |
| 6.03 (5.04 - 7.26) | 2002 | Modelled | IHME |
| 5.97 (4.94 - 7.17) | 2001 | Modelled | IHME |
| 6.03 (4.99 - 7.26) | 2000 | Modelled | IHME |
| 6.02 (4.94 - 7.25) | 1999 | Modelled | IHME |
| 5.75 (4.75 - 6.95) | 1998 | Modelled | IHME |
| 5.44 (4.49 - 6.53) | 1997 | Modelled | IHME |
| 5.45 (4.52 - 6.52) | 1996 | Modelled | IHME |
| 5.42 (4.49 - 6.50) | 1995 | Modelled | IHME |
| 5.42 (4.46 - 6.46) | 1994 | Modelled | IHME |
| 5.39 (4.44 - 6.44) | 1993 | Modelled | IHME |
| 5.42 (4.46 - 6.49) | 1992 | Modelled | IHME |
| 5.45 (4.42 - 6.57) | 1991 | Modelled | IHME |
| 5.48 (4.44 - 6.60) | 1990 | Modelled | IHME |
Showing out of
Show more
HBV-related deaths
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 5 (4 - 6) | 2019 | Modelled | IHME |
| 5 (4 - 6) | 2018 | Modelled | IHME |
| 5 (4 - 6) | 2017 | Modelled | IHME |
| 5 (4 - 6) | 2016 | Modelled | IHME |
| 4 (4 - 5) | 2015 | Modelled | IHME |
| 4 (4 - 5) | 2014 | Modelled | IHME |
| 4 (4 - 5) | 2013 | Modelled | IHME |
| 4 (4 - 5) | 2012 | Modelled | IHME |
| 4 (4 - 5) | 2011 | Modelled | IHME |
| 4 (3 - 5) | 2010 | Modelled | IHME |
| 4 (3 - 5) | 2009 | Modelled | IHME |
| 4 (3 - 5) | 2008 | Modelled | IHME |
| 4 (3 - 5) | 2007 | Modelled | IHME |
| 4 (3 - 5) | 2006 | Modelled | IHME |
| 4 (3 - 4) | 2005 | Modelled | IHME |
| 4 (3 - 4) | 2004 | Modelled | IHME |
| 4 (3 - 4) | 2003 | Modelled | IHME |
| 4 (3 - 4) | 2002 | Modelled | IHME |
| 4 (3 - 4) | 2001 | Modelled | IHME |
| 4 (3 - 4) | 2000 | Modelled | IHME |
| 4 (3 - 4) | 1999 | Modelled | IHME |
| 3 (3 - 4) | 1998 | Modelled | IHME |
| 3 (3 - 4) | 1997 | Modelled | IHME |
| 3 (3 - 4) | 1996 | Modelled | IHME |
| 3 (2 - 4) | 1995 | Modelled | IHME |
| 3 (2 - 4) | 1994 | Modelled | IHME |
| 3 (2 - 3) | 1993 | Modelled | IHME |
| 3 (2 - 3) | 1992 | Modelled | IHME |
| 3 (2 - 3) | 1991 | Modelled | IHME |
| 3 (2 - 3) | 1990 | Modelled | IHME |
Showing out of
Show more
Percent of liver cancer deaths attributable to HBV
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 54 (45 - 63) | 2019 | Modelled | IHME |
| 54 (45 - 63) | 2018 | Modelled | IHME |
| 54 (46 - 63) | 2017 | Modelled | IHME |
| 54 (46 - 63) | 2016 | Modelled | IHME |
| 54 (46 - 63) | 2015 | Modelled | IHME |
| 54 (46 - 63) | 2014 | Modelled | IHME |
| 54 (45 - 63) | 2013 | Modelled | IHME |
| 54 (46 - 62) | 2012 | Modelled | IHME |
| 54 (46 - 63) | 2011 | Modelled | IHME |
| 54 (45 - 63) | 2010 | Modelled | IHME |
| 54 (45 - 62) | 2009 | Modelled | IHME |
| 53 (45 - 62) | 2008 | Modelled | IHME |
| 53 (45 - 62) | 2007 | Modelled | IHME |
| 53 (45 - 62) | 2006 | Modelled | IHME |
| 53 (45 - 62) | 2005 | Modelled | IHME |
| 53 (44 - 62) | 2004 | Modelled | IHME |
| 53 (44 - 62) | 2003 | Modelled | IHME |
| 53 (45 - 62) | 2002 | Modelled | IHME |
| 53 (45 - 62) | 2001 | Modelled | IHME |
| 54 (46 - 63) | 2000 | Modelled | IHME |
| 54 (46 - 63) | 1999 | Modelled | IHME |
| 54 (46 - 63) | 1998 | Modelled | IHME |
| 55 (46 - 64) | 1997 | Modelled | IHME |
| 55 (46 - 63) | 1996 | Modelled | IHME |
| 55 (46 - 64) | 1995 | Modelled | IHME |
| 55 (47 - 64) | 1994 | Modelled | IHME |
| 55 (47 - 64) | 1993 | Modelled | IHME |
| 55 (47 - 65) | 1992 | Modelled | IHME |
| 55 (47 - 64) | 1991 | Modelled | IHME |
| 55 (47 - 65) | 1990 | Modelled | IHME |
Showing out of
Show more
Number of needles/syringes per PWID per year
People who inject drugs (PWID)
Download| Value | Year | Type | Source |
|---|---|---|---|
| 0 (0 - 0) | 2016 | Survey/reported | Harm Reduction International, 2016 |
Percent of PWID accessing OST
People who inject drugs (PWID)
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 0 | 2016 | Survey/reported | Harm Reduction International, 2016 |
Hepatitis C
Download HCV dataPrevalence of chronic HCV (RNA+/cAg)
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 0.29 (0.23 - 0.36) | 2019 | Modelled | IHME |
| 0.29 (0.23 - 0.36) | 2018 | Modelled | IHME |
| 0.29 (0.23 - 0.35) | 2017 | Modelled | IHME |
| 0.28 (0.23 - 0.35) | 2016 | Modelled | IHME |
| 0.28 (0.23 - 0.35) | 2015 | Modelled | IHME |
| 0.28 (0.23 - 0.35) | 2014 | Modelled | IHME |
| 0.28 (0.23 - 0.35) | 2013 | Modelled | IHME |
| 0.29 (0.23 - 0.35) | 2012 | Modelled | IHME |
| 0.29 (0.23 - 0.35) | 2011 | Modelled | IHME |
| 0.29 (0.23 - 0.35) | 2010 | Modelled | IHME |
| 0.28 (0.22 - 0.34) | 2009 | Modelled | IHME |
| 0.25 (0.20 - 0.31) | 2008 | Modelled | IHME |
| 0.22 (0.18 - 0.27) | 2007 | Modelled | IHME |
| 0.19 (0.16 - 0.23) | 2006 | Modelled | IHME |
| 0.18 (0.15 - 0.22) | 2005 | Modelled | IHME |
| 0.18 (0.15 - 0.22) | 2004 | Modelled | IHME |
| 0.18 (0.15 - 0.22) | 2003 | Modelled | IHME |
| 0.18 (0.15 - 0.22) | 2002 | Modelled | IHME |
| 0.18 (0.15 - 0.22) | 2001 | Modelled | IHME |
| 0.18 (0.15 - 0.22) | 2000 | Modelled | IHME |
| 0.19 (0.15 - 0.23) | 1999 | Modelled | IHME |
| 0.21 (0.17 - 0.25) | 1998 | Modelled | IHME |
| 0.23 (0.18 - 0.29) | 1997 | Modelled | IHME |
| 0.26 (0.21 - 0.32) | 1996 | Modelled | IHME |
| 0.28 (0.22 - 0.34) | 1995 | Modelled | IHME |
| 0.3 (0.24 - 0.36) | 1994 | Modelled | IHME |
| 0.31 (0.25 - 0.37) | 1993 | Modelled | IHME |
| 0.33 (0.27 - 0.39) | 1992 | Modelled | IHME |
| 0.34 (0.28 - 0.40) | 1991 | Modelled | IHME |
| 0.35 (0.29 - 0.42) | 1990 | Modelled | IHME |
Showing out of
Show more
HCV-related death rate
National
Download| Value (per 100,000) | Year | Type | Source |
|---|---|---|---|
| 3.79 (2.83 - 4.93) | 2019 | Modelled | IHME |
| 3.72 (2.80 - 4.81) | 2018 | Modelled | IHME |
| 3.66 (2.75 - 4.73) | 2017 | Modelled | IHME |
| 3.6 (2.74 - 4.63) | 2016 | Modelled | IHME |
| 3.55 (2.70 - 4.55) | 2015 | Modelled | IHME |
| 3.54 (2.71 - 4.50) | 2014 | Modelled | IHME |
| 3.5 (2.70 - 4.44) | 2013 | Modelled | IHME |
| 3.45 (2.67 - 4.33) | 2012 | Modelled | IHME |
| 3.37 (2.62 - 4.21) | 2011 | Modelled | IHME |
| 3.27 (2.56 - 4.09) | 2010 | Modelled | IHME |
| 3.2 (2.52 - 3.99) | 2009 | Modelled | IHME |
| 3.13 (2.45 - 3.91) | 2008 | Modelled | IHME |
| 3.05 (2.38 - 3.83) | 2007 | Modelled | IHME |
| 3 (2.34 - 3.79) | 2006 | Modelled | IHME |
| 2.91 (2.27 - 3.71) | 2005 | Modelled | IHME |
| 2.88 (2.24 - 3.70) | 2004 | Modelled | IHME |
| 2.89 (2.25 - 3.68) | 2003 | Modelled | IHME |
| 2.83 (2.19 - 3.63) | 2002 | Modelled | IHME |
| 2.82 (2.18 - 3.59) | 2001 | Modelled | IHME |
| 2.87 (2.22 - 3.65) | 2000 | Modelled | IHME |
| 2.9 (2.24 - 3.70) | 1999 | Modelled | IHME |
| 2.8 (2.17 - 3.58) | 1998 | Modelled | IHME |
| 2.66 (2.07 - 3.43) | 1997 | Modelled | IHME |
| 2.68 (2.08 - 3.47) | 1996 | Modelled | IHME |
| 2.67 (2.06 - 3.46) | 1995 | Modelled | IHME |
| 2.67 (2.04 - 3.47) | 1994 | Modelled | IHME |
| 2.66 (2.03 - 3.44) | 1993 | Modelled | IHME |
| 2.68 (2.04 - 3.47) | 1992 | Modelled | IHME |
| 2.7 (2.05 - 3.47) | 1991 | Modelled | IHME |
| 2.71 (2.06 - 3.51) | 1990 | Modelled | IHME |
Showing out of
Show more
HCV-related deaths
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 2 (2 - 3) | 2019 | Modelled | IHME |
| 2 (2 - 3) | 2018 | Modelled | IHME |
| 2 (2 - 3) | 2017 | Modelled | IHME |
| 2 (2 - 3) | 2016 | Modelled | IHME |
| 2 (2 - 3) | 2015 | Modelled | IHME |
| 2 (2 - 3) | 2014 | Modelled | IHME |
| 2 (2 - 3) | 2013 | Modelled | IHME |
| 2 (2 - 2) | 2012 | Modelled | IHME |
| 2 (1 - 2) | 2011 | Modelled | IHME |
| 2 (1 - 2) | 2010 | Modelled | IHME |
| 2 (1 - 2) | 2009 | Modelled | IHME |
| 2 (1 - 2) | 2008 | Modelled | IHME |
| 2 (1 - 2) | 2007 | Modelled | IHME |
| 2 (1 - 2) | 2006 | Modelled | IHME |
| 2 (1 - 2) | 2005 | Modelled | IHME |
| 2 (1 - 2) | 2004 | Modelled | IHME |
| 2 (1 - 2) | 2003 | Modelled | IHME |
| 2 (1 - 2) | 2002 | Modelled | IHME |
| 2 (1 - 2) | 2001 | Modelled | IHME |
| 2 (1 - 2) | 2000 | Modelled | IHME |
| 2 (1 - 2) | 1999 | Modelled | IHME |
| 2 (1 - 2) | 1998 | Modelled | IHME |
| 2 (1 - 2) | 1997 | Modelled | IHME |
| 2 (1 - 2) | 1996 | Modelled | IHME |
| 1 (1 - 2) | 1995 | Modelled | IHME |
| 1 (1 - 2) | 1994 | Modelled | IHME |
| 1 (1 - 2) | 1993 | Modelled | IHME |
| 1 (1 - 2) | 1992 | Modelled | IHME |
| 1 (1 - 2) | 1991 | Modelled | IHME |
| 1 (1 - 2) | 1990 | Modelled | IHME |
Showing out of
Show more
Percent of liver cancer deaths attributable to HCV
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 20 (14 - 27) | 2019 | Modelled | IHME |
| 20 (13 - 26) | 2018 | Modelled | IHME |
| 19 (13 - 26) | 2017 | Modelled | IHME |
| 19 (13 - 26) | 2016 | Modelled | IHME |
| 19 (13 - 26) | 2015 | Modelled | IHME |
| 20 (14 - 26) | 2014 | Modelled | IHME |
| 20 (14 - 26) | 2013 | Modelled | IHME |
| 20 (14 - 27) | 2012 | Modelled | IHME |
| 20 (13 - 26) | 2011 | Modelled | IHME |
| 20 (14 - 26) | 2010 | Modelled | IHME |
| 20 (14 - 26) | 2009 | Modelled | IHME |
| 20 (14 - 26) | 2008 | Modelled | IHME |
| 20 (14 - 26) | 2007 | Modelled | IHME |
| 20 (14 - 26) | 2006 | Modelled | IHME |
| 20 (13 - 26) | 2005 | Modelled | IHME |
| 20 (13 - 26) | 2004 | Modelled | IHME |
| 20 (14 - 26) | 2003 | Modelled | IHME |
| 20 (13 - 26) | 2002 | Modelled | IHME |
| 20 (13 - 26) | 2001 | Modelled | IHME |
| 19 (13 - 26) | 2000 | Modelled | IHME |
| 19 (13 - 26) | 1999 | Modelled | IHME |
| 19 (13 - 26) | 1998 | Modelled | IHME |
| 19 (13 - 26) | 1997 | Modelled | IHME |
| 19 (13 - 26) | 1996 | Modelled | IHME |
| 19 (13 - 26) | 1995 | Modelled | IHME |
| 19 (13 - 26) | 1994 | Modelled | IHME |
| 19 (13 - 26) | 1993 | Modelled | IHME |
| 19 (13 - 26) | 1992 | Modelled | IHME |
| 19 (13 - 26) | 1991 | Modelled | IHME |
| 20 (13 - 26) | 1990 | Modelled | IHME |
Showing out of
Show more
Number of needles/syringes per PWID per year
People who inject drugs (PWID)
Download| Value | Year | Type | Source |
|---|---|---|---|
| 300 (0 - 0) | 2016 | Survey/reported | Harm Reduction International, 2016 |
Percent of PWID accessing OST
People who inject drugs (PWID)
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 0 | 2016 | Survey/reported | Harm Reduction International, 2016 |
Overview
HBV elimination goal
HCV elimination goal
Prevalence (national)
Modelled
HBV (HBsAg+)
5.38
(%)
2019
(4.45 - 6.28(%))
IHME
HCV (RNA/cAg+)
0.29
(%)
2019
(0.23 - 0.36(%))
IHME
Survey/surveillance
No data available
No data available
Hepatitis related deaths (national)
Modelled
HBV
5
2019
(4 - 6)
IHME
Survey/surveillance
No data available
HBV chart
Modelled
HCV
2
2019
(2 - 3)
IHME
Survey/surveillance
No data available
HCV chart
Prevalence < 5
HBV
2.57
(%)
2019, latest modelled
(1.80 - 3.36(%))
IHME
Prevalence PWID
No data available
Birth dose vaccination coverage (national)
Survey/surveillance
No data available
No. of syringes/PWID/year
Survey/surveillance
HCV
0
2016
(0 - 0)
Harm Reduction International, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines